Management of toxicities from immunotherapy: European Society for Medical Oncology (ESMO) Clinical Practice Guideline for diagnosis, treatment and follow-up
This ESMO Clinical Practice Guideline provides key recommendations for managing immunotherapy-related toxicity.
The guideline covers assessment, diagnosis and treatment of the most common and severe immunotherapy-related toxicities.
Recommended assessment and treatment algorithms according to the grade of toxicity are provided.
The authors comprise a multidisciplinary group of experts from different institutions in Europe, Australia and the USA.
Recommendations are based on available scientific data and the authors’ collective expert opinion.